Voyager Therapeutics (VYGR) Financials: Revenue & Earnings

VYGR price $1.77 +0.04 +2.60%

Ticker
VYGR
Price
$1.77
Change
+0.04 +2.60%
Market cap ?
$109.37M
P/E ?
-0.96
Dividend yield ?
0.00%
Beta ?
1.28
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
46
Value
57
Quality
30
Growth
51

Stocklytics score rationale: value 57, quality 30, growth 51.

Financials

2016201720182019202020212022202320242025
1422000010135000761900010439100017112800037415000409070002500080008000100040374000

Voyager Therapeutics, Inc. operates as a gene therapy company, concentrating its efforts on developing innovative treatments and pioneering advanced platform technologies. Its leading clinical asset, VY-AADC, is presently undergoing an open-label Phase 1 clinical trial for the management of Parkinson's disease. The company's preclinical portfolio is extensive, featuring VY-SOD102 for amyotrophic lateral sclerosis…

Fair value

VYGR fair value $59.63. Price $1.77. Price is 97% below fair value.

Below fair value, and cheaper than usual. A larger discount than on 91% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 15.84M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 11.35% (beta 1.3). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 61.62M. Net debt -28.80M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare VYGR

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-09—-0.41—6.35M
2026-08-06-0.40-0.483.17M4.52M
2026-05-07-0.47-0.542.59M8.79M
2026-03-09-0.46-0.5415.34M10.49M
2025-11-10-0.47-0.5313.37M10.49M
2025-08-06-0.57-0.485.20M7.86M
2025-05-06-0.53-0.356.47M13.91M
2025-03-11-0.59-0.356.28M12.95M
2024-11-12-0.16-0.4524.63M15.46M
2024-08-06-0.18-0.3829.58M9.46M
2024-05-13-0.20-0.4419.52M9.41M
2024-02-281.25-0.2990.06M20.63M
2023-11-06-0.59-0.584.61M5.56M
2023-08-03-0.51-0.594.85M1.77M
2023-05-092.940.77150.48M61.11M
2023-03-07-0.61-0.5741.09M4.19M
2022-11-080.45-0.3241.09M9.42M
2022-08-04-0.50-0.56712.00K7.03M
2022-05-04-0.56-0.14658.00K12.71M
2022-03-080.15-0.3228.07M4.30M
2021-11-02-0.67-0.751.48M1.84M
2021-08-09-0.80-0.751.36M1.36M
2021-05-10-0.58-0.716.50M7.29M
2021-02-25-0.43-0.526.54M8.05M
2020-11-092.27-0.19117.84M1.48B
2020-08-10-0.23-0.7528.68M89.78M
2020-05-06-0.66-0.8718.07M21.63M
2020-03-03-0.34-0.8132.67M77.84M
2019-11-06-0.41-0.8320.43M37.88M
2019-08-090.29-0.7546.09M119.19M
2019-05-07-0.81-0.795.20M3.72M
2019-02-26-0.70-0.662.01M2.01M
2018-11-07-0.63-0.782.09M2.63M
2018-08-07-0.80-0.632.58M2.16M
2018-05-10-0.63-0.59942.00K164.48K
2018-03-14-0.40-0.726.34M11.42M
2017-11-02-0.89-0.721.15M928.72K
2017-08-08-0.73-0.621.18M984.36K
2017-05-09-0.65-0.541.46M1.19M
2017-03-15-0.57-0.452.36M1.91M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-06-09SCANGOS GEORGE ABuy30.00K$3.43102.90K
2026-06-09MACKEY CATHERINE JBuy30.00K$3.43102.90K
2026-06-09Hyman StevenBuy30.00K$3.43102.90K
2026-06-09Vitale NancyBuy30.00K$3.43102.90K
2026-06-09Higgins Michael JBuy30.00K$3.43102.90K
2026-06-09Onyia JudeBuy30.00K$3.43102.90K
2026-06-09GERAGHTY JAMES ABuy30.00K$3.43102.90K
2026-06-09Colon GraceBuy30.00K$3.43102.90K
2026-06-09PIERCE GLENNBuy30.00K$3.43102.90K
2026-05-08Quinlan AmyOther0——
2026-05-08Quinlan AmyOther50.00K$5.28264.00K
2026-05-08Quinlan AmyOther28.50K$3.68104.88K
2026-04-02Sandrock AlfredSell11.51K$3.8744.55K
2026-04-01Shiferman Gregory L.Buy50.00K——
2026-02-24Swartz RobinSell6.46K$3.7724.35K
2026-02-24Sandrock AlfredSell14.20K$3.7953.81K
2026-02-24Jorgensen Nathan D.Sell4.67K$3.7717.60K
2026-02-24Carter Todd AlfredSell4.17K$3.7615.69K
2026-02-18Swartz RobinSell3.88K$3.4413.35K
2026-02-18Carter Todd AlfredSell3.30K$3.4411.36K
2026-02-18Sandrock AlfredSell11.73K$3.4140.01K
2026-02-10Swartz RobinSell4.57K$3.8517.59K
2026-02-10Sandrock AlfredSell12.19K$3.7846.09K
2026-02-10Carter Todd AlfredSell3.52K$3.8513.57K
2026-02-06Ferguson TobyBuy210.00K$3.68772.80K
2026-02-06Ferguson TobyBuy45.00K——
2026-02-06Carter Todd AlfredBuy33.00K——
2026-02-06Carter Todd AlfredBuy154.00K$3.68566.72K
2026-02-06Swartz RobinBuy45.00K——
2026-02-06Swartz RobinBuy210.00K$3.68772.80K
2026-02-06Sandrock AlfredBuy86.25K——
2026-02-06Sandrock AlfredBuy402.50K$3.681.48M
2026-02-06Jorgensen Nathan D.Buy32.25K——
2026-02-06Jorgensen Nathan D.Buy150.50K$3.68553.84K
2026-01-06Shiferman Gregory L.Buy100.00K$4.02402.00K
2026-01-06Shiferman Gregory L.Other0——
2025-10-03Jorgensen Nathan D.Sell7.67K$4.7836.64K
2025-08-18Ferguson TobySell19.00K$3.7370.87K
2025-06-03Vitale NancyBuy24.00K$3.2878.72K
2025-06-03SCANGOS GEORGE ABuy24.00K$3.2878.72K
2025-06-03PIERCE GLENNBuy24.00K$3.2878.72K
2025-06-03Onyia JudeBuy24.00K$3.2878.72K
2025-06-03MACKEY CATHERINE JBuy24.00K$3.2878.72K
2025-06-03Hyman StevenBuy24.00K$3.2878.72K
2025-06-03Higgins Michael JBuy24.00K$3.2878.72K
2025-06-03GERAGHTY JAMES ABuy24.00K$3.2878.72K
2025-06-03Colon GraceBuy24.00K$3.2878.72K
2025-04-02Ferguson TobySell10.09K$3.4334.59K
2025-04-02Sandrock AlfredSell10.88K$3.4337.34K
2025-02-21Carter Todd AlfredBuy46.00K——
2025-02-21Carter Todd AlfredBuy92.00K$4.22388.24K
2025-02-21Sandrock AlfredBuy145.00K——
2025-02-21Sandrock AlfredBuy290.00K$4.221.22M
2025-02-21Swartz RobinBuy71.25K——
2025-02-21Swartz RobinBuy142.50K$4.22601.35K
2025-02-21Fahey Sandell JacquelynBuy41.50K——
2025-02-21Fahey Sandell JacquelynBuy83.00K$4.22350.26K
2025-02-21Ferguson TobyBuy63.00K——
2025-02-21Ferguson TobyBuy126.00K$4.22531.72K
2025-02-21Jorgensen Nathan D.Buy51.50K——
2025-02-21Jorgensen Nathan D.Buy103.00K$4.22434.66K
2025-02-20Carter Todd AlfredSell3.31K$4.2614.08K
2025-02-20Sandrock AlfredSell11.70K$4.2449.62K
2025-02-20Swartz RobinSell3.89K$4.2516.55K
2025-02-11Carter Todd AlfredSell5.41K$4.4524.09K
2025-02-11Swartz RobinSell6.95K$4.4530.93K
2025-02-11Sandrock AlfredSell16.64K$4.4574.07K
2025-02-11Fahey Sandell JacquelynSell4.36K$4.4519.39K
2025-01-14Swartz RobinSell3.09K$5.0915.71K
2025-01-14Carter Todd AlfredSell1.19K$5.136.11K
2024-12-23Swartz RobinSell6.50K$5.6536.73K
2024-10-02Fahey Sandell JacquelynSell6.00K$5.8234.91K
2024-10-01Jorgensen Nathan D.Buy80.00K——
2024-07-08Jorgensen Nathan D.Buy200.00K$7.791.56M
2024-07-08Jorgensen Nathan D.Other0——
2024-06-05Vitale NancyBuy24.00K$8.70208.80K
2024-06-05SCANGOS GEORGE ABuy24.00K$8.70208.80K
2024-06-05PIERCE GLENNBuy24.00K$8.70208.80K
2024-06-05Onyia JudeBuy24.00K$8.70208.80K
2024-06-05MACKEY CATHERINE JBuy24.00K$8.70208.80K
2024-06-05Hyman StevenBuy24.00K$8.70208.80K
2024-06-05Higgins Michael JBuy24.00K$8.70208.80K
2024-06-05GERAGHTY JAMES ABuy24.00K$8.70208.80K
2024-06-05Colon GraceBuy24.00K$8.70208.80K
2024-04-02Swartz RobinSell1.36K$9.8813.41K
2024-04-02Sandrock AlfredSell12.12K$9.86119.45K
2024-04-01Ferguson TobyBuy105.00K——
2024-03-25Ferguson TobyBuy210.00K$9.261.94M
2024-03-25Ferguson TobyOther0——
2024-02-21Swartz RobinSell3.97K$7.4529.55K
2024-02-21Sandrock AlfredSell13.03K$7.4697.23K
2024-02-21PFREUNDSCHUH PETER P.Sell3.76K$7.4628.08K
2024-02-21Carter Todd AlfredSell3.37K$7.4725.14K
2024-02-20Carter Todd AlfredSell602$7.684.62K
2024-02-09Fahey Sandell JacquelynBuy31.00K——
2024-02-09Fahey Sandell JacquelynBuy62.00K$7.60471.20K
2024-02-09Carter Todd AlfredBuy38.50K——
2024-02-09Carter Todd AlfredBuy77.00K$7.60585.20K
2024-02-09Swartz RobinBuy50.00K——
2024-02-09Swartz RobinBuy100.00K$7.60760.00K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 144, holders +5 vs prior quarter. Ownership 58.15%.

HolderSharesChangeChange %Value
BLACKROCK, INC.5.17M-396.32K-7.12%18.10M
MILLENNIUM MANAGEMENT LLC4.44M1.01M+29.59%15.55M
ARMISTICE CAPITAL, LLC3.44M-64.00K-1.83%12.03M
VESTAL POINT CAPITAL, LP2.62M-377.94K-12.59%9.19M
VANGUARD CAPITAL MANAGEMENT LLC2.35M62.42K+2.73%8.21M
GEODE CAPITAL MANAGEMENT, LLC1.33M280.51K+26.72%4.66M
OPALEYE MANAGEMENT INC.1.19M35.00K+3.04%4.15M
STATE STREET CORP1.08M128.20K+13.52%3.77M
TWO SIGMA INVESTMENTS, LP948.52K332.86K+54.07%3.32M
DIMENSIONAL FUND ADVISORS LP838.18K-37.38K-4.27%2.93M
VANGUARD PORTFOLIO MANAGEMENT LLC810.09K84.32K+11.62%2.84M
CITADEL ADVISORS LLC784.07K770.57K+5707.90%2.74M
MORGAN STANLEY697.33K15.62K+2.29%2.44M
ERSTE ASSET MANAGEMENT GMBH638.90K-456.24K-41.66%2.29M
RENAISSANCE TECHNOLOGIES LLC495.24K-82.79K-14.32%1.73M
SPHERA FUNDS MANAGEMENT LTD.427.55K-42.21K-8.98%1.50M
ACADIAN ASSET MANAGEMENT LLC428.67K179.80K+72.25%1.50M
DIADEMA PARTNERS LP413.64K263.64K+175.76%1.45M
NORTHERN TRUST CORP411.80K26.96K+7.01%1.44M
AQR CAPITAL MANAGEMENT LLC356.11K123.43K+53.05%1.25M
GOLDMAN SACHS GROUP INC338.48K-89.12K-20.84%1.18M
VANGUARD FIDUCIARY TRUST CO337.32K39.00K+13.07%1.18M
FIDUCIARY TRUST CO334.40K00.00%1.17M
JPMORGAN CHASE & CO276.21K-656-0.24%988.84K
POINT72 ASSET MANAGEMENT, L.P.236.08K-32.14K-11.98%826.29K

Earnings and financials

Voyager Therapeutics, Inc. (VYGR) trades at $1.77, with a market cap of $109.37M and a trailing P/E of -0.96. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
1422000010135000761900010439100017112800037415000409070002500080008000100040374000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Voyager Therapeutics (VYGR) Financials: Revenue & Earnings

VYGR$1.77+0.04 +2.60%

$109.37M

Market Cap

-0.96

P/E

—

Forward P/E

46

Score

Price History